. Relative to the pancreatic lesion(s) in AIP, extrapancreatic lesions may appear synchronously or metachronously [29] , share the same pathological conditions, and show favorable response to corticosteroid therapy. These characteristics indicate a common pathophysiological background, which suggests the presence of a systemic a b IgG4-related disease [30] . The lesions are typically detected with imaging (CT, MRI, gallium scintigraphy, FDG-PET) [2, 31, 32] and blood tests (hormone assays), but results should be confirmed with histological findings. Extrapancreatic lesions sometimes mimic or are misdiagnosed as primary lesions in the corresponding organ. For example, lachrymal and salivary gland lesions may be mistaken for Sjögren's syndrome, respiratory lesions may be mistaken for sarcoidosis, and sclerosing cholangitis may be mistaken for primary sclerosing cholangitis (PSC). Therefore, it is necessary to distinguish between IgG4-related diseases and diseases that arise from the corresponding organ. When a pancreatic lesion is obscure, it may be difficult to detect IgG4-related extrapancreatic lesions. However, recognition of these extrapancreatic lesions should aid in accurate diagnosis of AIP.
CQ-II-1-2. How are extrapancreatic lesions diagnosed?
• The diagnosis of extrapancreatic lesions complicated with AIP is based on clinical findings that suggest a close association between the lesion and AIP activity, including characteristic pathological findings, a favorable response to corticosteroid therapy, and distinct differentiation from similar lesions due to other causes in the corresponding organ.
(Level of recommendation: B)
Description Several lines of evidence support the theory that extrapancreatic lesions are associated with AIP, including (1) frequent or coincident occurrence; (2) pathological findings of severe lymphoplasmacytic infiltration and storiform fibrosis, IgG4-positive plasma cell infiltrations, and obliterative phlebitis; (3) favorable response to corticosteroid therapy or synchronous response to therapies; and (4) distinct differentiation from the lesions of the corresponding organ, such as a distinction between AIPassociated salivary gland lesions and those due to Sjögren's syndrome. Among the many possible extrapancreatic lesions listed in Table 1 , the following fulfill the above criteria: lachrymal and salivary gland lesions, respiratory lesions, sclerosing cholangitis, retroperitoneal fibrosis, and tubulointerstitial nephritis.
CQ-II-1-3.: What are the differences between lachrymal and salivary gland lesions associated with AIP and those associated with Sjögren's syndrome?
• Description The presence of symmetrical lachrymal and salivary gland lesions has been noted in approximately 14-39 % of patients with AIP ( Fig. 1 ) [12, 26, 27, 33] . These lesions, which were previously thought to be a complication of Sjögren's syndrome, are now thought to be related to Mikulicz's disease or Küttner's tumor (chronic sclerosing sialadenitis) [34, 35] . Useful findings for differentiating among these possibilities include the following: (1) compared to those of Sjögren's syndrome, AIPassociated lachrymal and salivary gland lesions show normal or slightly impaired exocrine function, presenting as a slight or negligible dryness in the eyes and mouth [33, 36] ; (2) salivary gland lesions associated with AIP appear predominantly in the submandibular gland [31] , and those associated with Sjögren's syndrome frequently appear in the parotid gland [37] ; (3) lachrymal and salivary gland lesions associated with AIP show negative results in tests for SS-A/Ro and SS-B/La autoantibodies [35] ; (4) lachrymal and salivary gland lesions associated with AIP show numerous IgG4-positive plasma cell infiltrations in the affected tissues [35] ; and (5) lachrymal and salivary gland lesions associated with AIP respond favorably to corticosteroid therapy [35] . Most lesions are bilateral and symmetrically distributed, but a few cases may exhibit unilateral lesions. To ensure accurate diagnosis, a salivary gland biopsy is preferable, but the less invasive lip biopsy can be substituted for examinations of the small salivary gland. AIP complicated with lachrymal and salivary gland lesions represents a highly active state, with higher serum IgG4 concentrations and more severe pancreatic swelling compared to AIP without complications [27, 38] . When diagnosing AIP-associated lachrymal and salivary gland lesions, it is recommended to refer to the diagnostic criteria for IgG4? Mikulicz's disease [39] .
CQ-II-1-4. What kind of respiratory lesions are associated with AIP?
• Respiratory lesions associated with AIP include interstitial lung disease, asthma, inflammatory pseudotumor of the lung, edema and swelling of the tracheobronchial mucosa, thickening of the bronchial wall and bronchial vascular bundle, pleural lesions, and hilar or mediastinal lymphadenopathy. The lesions must be differentiated from idiopathic interstitial pneumonia, sarcoidosis, and lung tumor. Similar to AIP-associated pancreatic lesions, the pathology of these AIP-associated lesions includes numerous IgG4-bearing plasma cell infiltrations and a favorable response to corticosteroid therapy. (Level of recommendation: B)
Description Interstitial lung disease complicated with AIP has been noted in approximately 8-13 % of patients [3, 4] . This condition exhibited high serum KL-6 levels and alveolar IgG4-bearing plasma cell infiltrations [3, 4, 16] . Thoracic CT showed various lung lesions, bronchial wall thickening, nodules, interlobular thickening, infiltration in the middle and lower lung fields (Fig. 3a, b ) [28] , and honeycombing in the lower lung field [40] . While IgG4-related respiratory lesions of interstitial pneumonia, nodular lesions, localized ground glass-opacity (GGO), and pleural lesions sometimes occurred without a pancreatic lesion [16, [41] [42] [43] [44] [45] , a definitive diagnosis of IgG4-related respiratory lesions was difficult in patients with intrathoracic lesions alone, as IgG4-bearing plasma cells have also been observed in other types of lung lesions [46] .
Another respiratory lesion associated with AIP is inflammatory pseudotumor of the lung [47] . Although inflammatory pseudotumors comprise various subtypes, the lesion associated with AIP corresponds to a plasma cell granuloma, which shows lymphoplasmacytic infiltration, fibrosis, obstructive phlebitis, and IgG4-bearing plasma cell infiltration characteristics that are similar to those of a pancreatic lesion in AIP [47] . In addition, obstructive arteritis is sometimes considered a lung lesion. An inflammatory pseudotumor is often suspected to be a lung tumor, which may result in inappropriate resection. However, unlike a lung tumor, the inflammatory pseudotumor responds favorably to corticosteroid therapy (Fig. 3c, d ) [28] .
Gallium scintigraphy has revealed hilar and mediastinal lymphadenopathy in 67-75 % of patients with AIP. In these cases, bronchoscopy and CT sometimes reveal edema and swelling of the tracheobronchial mucosa as well as thickening of the bronchial wall and bronchial vascular bundle. While these finding are consistent with the characteristics of sarcoidosis (Fig. 3e, f) , patients with AIP showed normal serum angiotensin-converting enzyme (ACE) levels [2, 31, 44, 45, 48, 49] .
CQ-II-1-5. How is AIP-associated sclerosing cholangitis differentiated from PSC or biliary malignancies?
• Differentiation between AIP-associated sclerosing cholangitis (IgG4-related sclerosing cholangitis) and PSC or biliary malignancies should be ascertained carefully based on a combination of clinical features, pathological findings, and imaging tests such as cholangiography, ultrasonography, endoscopic ultrasonography (EUS), intraductal ultrasonography (IDUS), CT, and MRI. (Level of recommendation: A)
Description AIP-associated sclerosing cholangitis, also known as IgG4-related sclerosing cholangitis, is characteristically considered a lower (intrapancreatic) bile duct stenosis, although is sometimes distributed widely across the biliary system. It may exhibit restricted stenosis from the hilar to the extrahepatic bile ducts or multiple stenosis in the intrahepatic bile ducts (Fig. 4) [50] . The lower bile duct lesions must be differentiated from pancreatic cancer or common bile duct cancer; intrahepatic and hilar bile duct lesions must be differentiated from PSC and cholangiocarcinoma, respectively.
There are several differences between IgG4-related sclerosing cholangitis and PSC. IgG4-related sclerosing cholangitis has shown a preponderance among older males and is frequently complicated with obstructive jaundice [51] [52] [53] . In contrast, PSC has been more commonly found in young and middle-aged patients, sometimes complicated with inflammatory bowel diseases [12, [51] [52] [53] . Cholangiography of IgG4-related sclerosing cholangitis reveals lower bile duct stenosis and relatively long strictures from the hilar to the intrahepatic biliary systems, with simple distal dilations [51, 52] . Cholangiography of PSC characteristically shows band-like strictures (short strictures of 1-2 mm), a beaded appearance, a pruned tree appearance, or diverticulum-like outpouching (Fig. 5) [51, 52, 54] . Ultrasonography of IgG4-related sclerosing cholangitis has revealed wall thickening of the intra-or extrahepatic bile ducts. Moreover, histological examinations of the bile duct wall in IgG4-related sclerosing cholangitis have shown similar pathology to that observed in pancreatic tissue [55] [56] [57] . Inflammation associated with IgG4-related sclerosing cholangitis is found throughout all the layers of the bile duct wall, while inflammation associated with PSC is found predominantly in the inner wall portion, with only slight changes in the outer wall portion of the bile duct. Liver biopsies have shown several IgG4-bearing plasma cell infiltrations in the portal area in IgG4-related sclerosing cholangitis, but only a few in PSC [20, 52, [55] [56] [57] .
IgG4-related sclerosing cholangitis sometimes shows slight or no pancreatic lesions, which may lead to a misdiagnosis of PSC [53, 58, 59] . Even without pancreatic swelling, pancreatography sometimes discloses irregular narrowing of the main pancreatic duct (MPD), which suggests that an endoscopic retrograde cholangiopancreatography (ERCP) would be very useful in those situations [59] . IgG4-related sclerosing cholangitis with localized bile duct stenosis must be differentiated from bile duct cancer [60, 61] . Because it is sometimes difficult for cholangiography alone to differentiate between these conditions, it is necessary to perform a careful examination with other tests such as EUS, IDUS, cytology, and tissue biopsy [60] [61] [62] [63] . Although a finding of IgG4-bearing plasma cell infiltrations in the bile duct wall supports the diagnosis of IgG4-related sclerosing cholangitis [53, 58] , some reports have denied the diagnostic utility of a bile duct biopsy [63] . Characteristic IDUS findings are a thickening of the inner hypoechoic zone and the preservation of the luminal and outer hyperechoic zones [63, 64] . In some studies, IDUS showed a thickening of the bile duct wall, whereas cholangiography showed normal findings [63] . These characteristic findings will aid in differentiating between the two conditions (also see CQII-1.6). IgG4-related sclerosing cholangitis may also exhibit an inflammatory pseudotumor, like an outgrowing tumor of the bile duct [55] , which can be misdiagnosed as bile duct cancer.
IgG4-related sclerosing cholangitis is frequently complicated with gallbladder lesions, and thus a thickening of the gallbladder wall can provide a clue for accurate diagnosis [65] . When diagnosing IgG4-related sclerosing cholangitis, it is recommended to refer to the clinical diagnostic criteria for IgG4-related sclerosing cholangitis [66] .
CQ-II-1-6. What IDUS findings are characteristic of IgG4-related sclerosing cholangitis?
• Lower bile duct stenosis associated with AIP is caused by two mechanisms: (1) extrinsic compression by a swollen pancreas head, and (2) Description IgG4-related sclerosing cholangitis is characterized by lower and upper bile duct stenosis. Lower bile duct stenosis is caused by two mechanisms: extrinsic compression from a swollen pancreatic head (Fig. 6a) and thickening of the bile duct wall (Fig. 6b) [28, 63, 67] . Lower bile duct stenosis is frequently observed in cases of pancreatic head swelling, and lower bile duct wall thickening has been reported to be proportional to the degree of bile duct stenosis [67] . In contrast to bile duct cancer, IgG4-related sclerosing cholangitis shows concentric wall thickening and delayed enhancement with Levovist [68, 69] .
In IgG4-related sclerosing cholangitis, upper bile duct changes are predominantly observed in the hilar to intrahepatic bile duct system. These changes are reminiscent of those observed in PSC, where IDUS revealed thickening of the inner hypoechoic zone (Fig. 6c) [63] . Although differentiation is difficult with IDUS alone, in PSC, the IDUS changes include a slight luminal dilation and an irregular surface (Fig. 6d) . In contrast to bile duct cancer, for which IDUS showed destruction of outer hyperechoic zone (Fig. 6e) , in IgG4-related sclerosing cholangitis, the IDUS commonly shows preservation of the outer hyperechoic zone [63] .
In some studies, IDUS showed a thickening of the bile duct wall, whereas cholangiography showed normal findings; the wall of the corresponding region was reported to be thicker than 0.8 mm [63] . Although bile duct wall thickening is predominantly observed in cancer invasion or PSC [70] , biliary drainage also induces thickening of the bile duct wall, and therefore IDUS survey should be performed before biliary drainage [70] .
The changes detected by cholangiography in IgG4-related sclerosing cholangitis are promptly ameliorated with corticosteroid therapy. The thickening of the bile duct wall detected with IDUS is also ameliorated in parallel with decreases in cell infiltration and edema, which result in an increased echo level in a thickened wall. However, unlike the amelioration evident with cholangiography, the changes detected with IDUS tend to persist after corticosteroid therapy.
CQ-II-1-7. What findings are characteristic of retroperitoneal fibrosis associated with AIP?
• CT and MRI are commonly used to detect morphologic findings characteristic of retroperitoneal fibrosis. These findings include soft tissue densities that represent masses around the ureter and aorta, near the vertebra, or in the pelvic cavity. Description AIP-associated retroperitoneal fibrosis is characterized by morphologic findings detected in CT and MRI analyses, including soft tissue densities that represent masses around the aorta (Fig. 2a, b ) and the ureter (Fig. 2c) , near the vertebra, or in the pelvic cavity. There may also be increased fat density around the superior mesenteric artery [7, 31] . In addition, with positron emission tomography combined with fludeoxyglucose (FDG-PET), intense FDG uptake is typically observed in the corresponding lesions [71] . Histological studies of biopsy specimens have revealed numerous IgG4-bearing plasma cell infiltrations and obstructive phlebitis [7, 72] . Soft tissue masses around the ureter sometimes induce ureteral strictures, which may result in hydronephrosis and irreversible renal failure [73] . These lesions typically respond favorably to corticosteroid treatment [7] . Some cases exhibit periaortitis with adventitial hypertrophy or aneurysm. These findings have been described as an IgG4-related inflammatory abdominal aortic aneurysm [74] . However, it is not certain whether these lesions occurred as a consequence of soft tissue masses around the aorta [22] .
CQ-II-1-8. What findings are characteristic of AIPassociated kidney disease?
• AIP-associated kidney disease is referred to as IgG4-related kidney disease; most lesions represent tubulointerstitial nephritis. (Level of recommendation: B).
• Dynamic contrast-enhanced CT and MRI show poorlyenhanced multiple nodules, wedge-shaped lesions, or round lesions in the renal cortex, and mass lesions in the renal pelvis. (Level of recommendation: B).
Description AIP-associated kidney disease is also known as IgG4-related kidney disease. Most lesions are considered tubulointerstitial nephritis [8, 9, 75, 76] , and thus a slight urinary finding is common. Renal function is typically normal or slightly impaired, but in some cases, renal failure may occur after severe renal damage. A blood test frequently reveals hypocomplementemia, and it may also show abnormal findings similar to those found in IgG4-related diseases [76] . AIP-associated kidney disease seldom shows glomerular lesions such as membranous nephropathy [77] . Dynamic contrast-enhanced CT or MRI typically reveals poorly enhanced multiple nodules, wedge-shaped lesions, or round lesions in the renal cortex, or a mass in the renal pelvis. A localized renal distribution is characteristic (Fig. 7 ) [31, 78] . Histological analyses of biopsy specimens typically reveal abundant lymphoplasmacytic and slight eosinophilic infiltrations in the tubulointerstitial region. Renal lesions are relatively localized, and they extend from the deep medulla to the outside of the renal capsule. Some reports have described IgG, IgG4, and complement deposits at the basement membranes of the renal tubule [76, 79] . When diagnosing kidney disease, it is recommended to refer to the diagnostic criteria for IgG4-related kidney disease [80] .
II-2. Differential diagnosis
CQ-II-2-1. What clinical symptoms or findings are useful for differentiating between AIP and pancreatic cancer?
• Useful clinical findings for differentiating between AIP and pancreatic cancer include abdominal pain, weight Description Abdominal pain in pancreatic cancer is severe, persistent, and progressive, sometimes requiring treatment with narcotics. In contrast, abdominal pain in AIP is mild and may be described as simply discomfort of the upper abdomen. [30, [81] [82] [83] [84] [85] [86] [87] . Weight loss, which is frequently observed in pancreatic cancer, is rare in AIP, although weight loss in patients with AIP may occur in cases where diabetes mellitus is not under control. Jaundice in pancreatic cancer is progressive; in AIP, jaundice occasionally fluctuates, spontaneously subsides, and responds well to corticosteroid therapy [30, [81] [82] [83] [84] [85] [86] [87] . Symptoms associated with various extrapancreatic lesions in AIP include swelling of the lachrymal and salivary glands, jaundice due to sclerosing cholangitis, hydronephrosis due to retroperitoneal fibrosis, hypothyroidism, hypophysitis, and prostatitis [30, [81] [82] [83] [84] [85] [86] [87] . In pancreatic cancer, the symptoms associated with apparent extrapancreatic lesions are restricted to lower bile duct stenosis, metastatic lesions, or direct invasions (Table 2 ) [28] .
CQ-II-2-2. Does a high serum IgG4 concentration rule out the possibility of pancreatic cancer?
• In terms of sensitivity, specificity, and accuracy, elevated IgG4 is the best marker for differentiating between AIP and pancreatic cancer, although a few patients with pancreatic cancer have reported high serum IgG4 concentrations. Therefore, high serum IgG4 concentration cannot completely rule out the presence of pancreatic cancer.
(Level of recommendation: B)
Description A high serum IgG4 concentration is commonly found in AIP [53, 84, 87, 88] . In normal subjects, IgG4 comprises 4-6 % of total IgG, and IgG4 serum elevations have been known to occur in a few specific conditions such as allergic diseases, parasite infestations, and pemphigus vulgaris. As serum IgG4 elevations are rarely found in other pancreatic diseases and related autoimmune diseases such as pancreatic cancer, chronic pancreatitis, primary biliary cirrhosis, PSC, and Sjögren's syndrome, a high serum IgG4 concentration is fairly specific to AIP. Furthermore, a finding of numerous IgG4-bearing plasma cell infiltrations in pancreatic tissue is a diagnostic hallmark [7] .
In differentiating between AIP and pancreatic cancer, a comparison of various serum markers showed that the best results were obtained with IgG4, with 86 % sensitivity, 96 % specificity, and 91 % accuracy (Table 3 ) [28] . IgG4 was adopted as the best marker in Japanese diagnostic criteria for 2006 and 2011 and for the International Consensus Diagnostic Criteria for AIP [83, 89] . However, serum IgG4 elevations or numerous IgG4-bearing plasma cell infiltrations have been found in a few patients with pancreatic cancer [87] , suggesting that a high serum IgG4 concentration and increased IgG4-positive plasma cell infiltrations in pancreatic tissue is not completely specific for AIP. Therefore, these findings cannot exclude the presence of pancreatic cancer. • Description AIP sometimes reveals a focal mass on CT and MRI, which should be distinguished from those detected in pancreatic cancer (Fig. 8a) . Pancreatic swellings found in AIP improved dramatically after corticosteroid therapy (Fig. 8b) . Because pancreatic mass lesions are more common in pancreatic cancer than in AIP, close attention is warranted when diagnosing masses related to AIP requires.
A characteristic finding in AIP is a capsule-like rim that appears on CT and MRI of the pancreatic margin [90] [91] [92] . This rim is prominent at the body and tail regions of the pancreas and represents severe fibrotic changes (Fig. 9 ). CT and MRI of an aged pancreas have revealed a lobulated margin and a cobblestone-like texture. In contrast, imaging b a Fig. 8 Localized pancreatic mass in AIP. a Dynamic contrastenhanced CT (arterial phase) shows poorly-enhanced localized mass in the pancreatic head (arrows). b After corticosteroid therapy, the pancreatic swelling decreased in size and the localized mass disappeared Fig. 9 CT image of typical diffuse type of AIP. Dynamic contrastenhanced CT shows the pancreas with diffuse swelling, a smooth margin, and a capsule-like rim in a patient with AIP of a pancreas with AIP showed a smooth margin, likely due to early stage of the disease (Fig. 9) .
Dynamic contrast-enhanced CT with a rapid infusion of contrast material is essential for CT analysis of pancreatic lesions. In the early (pancreatic parenchymal) phase, the contrast material stains the parenchyma of normal pancreatic tissues; in the late phase, the contrast medium reaches equilibrium between intra-and extravascular fluids. Intense staining in the late phase indicates fibrosis. A contrast-enhanced CT of the AIP pancreas shows delayed homogeneous enhancement in pancreatic mass lesions, which indicates widespread loss of the parenchyma and severe fibrosis (Fig. 10a, b) . A contrast-enhanced CT of pancreatic cancer also shows delayed enhancement. However, unlike AIP, the staining pattern shows heterogeneous enhancement (Fig. 10c, d) , reflecting necrosis or bleeding in the tumor [91, 93] .
T1-weighted images are essential for MRI analysis of pancreatic lesions. In combination with the fat-suppressed method, this approach can detect detailed changes in the pancreatic parenchyma. Fat-suppressed T1-weighted MR images of a normal pancreas show high signal intensity compared to those of the liver (Fig. 11a) ; in contrast, those of a pancreas with AIP show a reduced signal, reflecting the loss of normal parenchyma (Fig. 11b) [28] . Histological analyses of resected AIP-affected pancreatic tissues frequently show a mixture of normal and inflammatory pancreatic tissues [94] . Accordingly, fat-suppressed T1-weighted MR images sometimes show a speckled/dotted hyper-intense region that is enhanced in the pancreatic phase of dynamic contrastenhanced MRI of the affected mass lesion. This finding is useful for distinguishing AIP from pancreatic cancer, as these lesions show high densities in the early phase [95] . T2-weighted MR images of the pancreas with AIP generally reveal high-intensity signals, reflecting severe lymphoplasmacytic infiltration. T2-weighted MR images of the pancreas with AIP sometimes show the main pancreatic duct (MPD) clearly penetrating through the mass lesion, which is a useful sign for differentiating between AIP and pancreatic cancer [96] (Fig. 11c, d ) [28] . However, reports have indicated that the frequency of this occurrence is no different between a small focal AIP and pancreatic cancer [95] .
In AIP, CT and MRI sometimes show wall thickening in the gallbladder and bile duct, even in the absence of duct a b c d stenosis (Fig. 12 ) [28, 91, 92] . These findings are rare in pancreatic cancer. The findings discussed above are characteristic of AIP in an active stage. However, AIP may progress to intraductal stone formation after several relapses, resulting in pancreatic juice stasis and severe calcification. In this instance AIP becomes indistinguishable from ordinary chronic pancreatitis (Fig. 13) [28, [97] [98] [99] .
Similar to ERCP, magnetic resonance cholangiopancreatography (MRCP) of the pancreas with AIP also shows narrowing of the MPD but with low resolution. ERCP findings that differentiate AIP from pancreatic cancer include a longer stenosis in the MPD (more than 3 cm), the presence of branches in the stenosed MPD region, and, after a stenosis of less than 4 mm, a non-dilated MPD [100, 101] . These findings are not possible to discern in cases with MPD obstruction. However, MRCP can image the distal duct even when ERCP shows only obstruction. While MRCP can detect MPD dilation in AIP, it provides comparatively poor images of MPD narrowing or side branches compared to ERCP [102] . Like ERCP, MRCP of the MPD typically shows mild or no distal dilation in AIP (Fig. 14a) [28, 102] but prominent dilation in pancreatic cancer (Fig. 14b) .
FDG-PET reveals intense FDG accumulation at a high rate in the pancreatic lesions of both AIP and pancreatic cancer. In AIP, the pancreatic distribution is diffuse, with signals at multiple sites, while the signal is restricted to a solitary site in pancreatic cancer, [32, 103] . FDG accumulation in AIP also appears at extrapancreatic sites, such as the lachrymal and salivary glands or the hilar lymph node. These features are useful for distinguishing between AIP and pancreatic cancer [32, 103, 104] . Another useful differentiating feature in AIP is a rapid decrease in FDG accumulation after corticosteroid therapy [104, 105] . Description Although few studies have described EUS findings that may differentiate between AIP and pancreatic cancer or chronic pancreatitis, some findings that may be useful can be deduced from EUS or US studies of each disease [106] [107] [108] [109] [110] . Typical EUS of the pancreas with AIP has revealed a diffuse hypoechoic pattern [106] [107] [108] [109] [110] [111] ( Fig. 15a ) [28] , reflecting severe inflammatory cell infiltration. EUS of the pancreas in chronic pancreatitis has shown a heterogeneous echo pattern even when inflammatory changes were severe. Hyperechoic inclusions have been found in both conditions, but in AIP they occurred less frequently and characteristically presented as linear or reticular (tortoiseshell) patterns against the hypoechoic background in the post-acute phase (Fig. 15b ) [28] . These findings may represent interlobular fibrosis. Unlike AIP, chronic pancreatitis generally has a lobule-shaped pancreatic margin, a hyperechoic ductal margin, calcification, and cysts. In addition, the hyperechoic inclusions in AIP sometimes promptly disappear with corticosteroid treatment. Although a localized mass with a hypoechoic pattern has been reported in EUS studies of both AIP and pancreatic cancer, only AIP is generally associated with linear or reticular (tortoiseshell pattern) hyperechoic inclusions (Fig. 15c ) [28] and the duct-penetrating sign (Fig. 15d ) [28, 111] . While EUS findings of lymph node swelling and vascular invasion are typically associated with pancreatic cancer, it is sometimes difficult to distinguish between the two conditions, and EUS-FNA may be required [112] . EUS-FNA is an excellent diagnostic tool for discounting pancreatic cancer due to its high specificity (98-100 %), but it cannot provide a definitive diagnosis of AIP due to the small sample volume [113] [114] [115] .
CQ-II-2-5. What pathological findings are useful for differentiating AIP from pancreatic cancer?
• • Neutrophilic infiltrates, lymphocyte-predominant infiltrates with scarce plasma cells, and proliferation of plump fibroblasts are more common in pancreatic cancer than in AIP, although these findings should not be regarded as sole diagnostic criteria for differentiation. (Level of recommendation: B)
Description Diagnosis of pancreatic cancer by pathological findings may be confirmed by histological identification of carcinoma cells, which is normally easy with resected specimens. Because EUS-FNA is specific for the diagnosis of pancreatic cancer, it provides a useful method to exclude the presence of pancreatic cancer [113, 114] . However, it is common to observe inflammatory reactions around pancreatic cancer, and cautious interpretation of biopsy specimens with inflammatory changes is necessary to ensure accurate diagnosis of AIP. There is insufficient evidence regarding the differentiation between AIP and pancreatic cancer based on pathological findings. Neutrophilic infiltrates, inflammatory infiltrates and edema in the lobules, proliferation of plump fibroblasts, and lymphocyte-predominant infiltrates with scarce plasma cells are more common in pancreatic cancer than in AIP (Fig. 16a ) [28] . Numerous plasma cell infiltration is regarded as a characteristic of AIP, whereas predominant lymphocytic infiltration with scarce plasma cell is preferentially found at inflammatory sites of pancreatic cancer (Fig. 16b) [28] . These findings in isolation should not be regarded as definitive diagnostic indications for AIP. In addition, lymphoid follicles are commonly seen in both pancreatic cancer and AIP, and should not be regarded as a diagnostic hallmark of AIP. While periductal lymphoplasmacytic infiltrates and obstructive phlebitis are characteristic findings for AIP, these are rarely found in biopsy specimens, and histological diagnosis using biopsy specimens is difficult [116] . A few reports showed clear significance of EUS-FNA in the histological diagnosis of AIP [115, 117] . Conversely, EUS TruCut biopsy with IgG4 immunostaining was reported to be useful for the diagnosis of AIP [115, 117] .
CQ-II-2-6. Are the histological features characteristic of AIP observed in pancreatic cancer?
• Description Rare pancreatic cancers reveal histological features that resemble AIP (Fig. 17a) [28, [118] [119] [120] . Few histological studies of pancreatic cancer concomitant with AIP have been reported. Irrespective of these characteristic findings, numerous IgG4-positive plasma cells are occasionally identified in pancreatic cancer (Fig. 17b) [28, 116, 121, 122] .
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